In recent years, the significance of metered dose inhalers has escalated dramatically, particularly in the context of respiratory care. The latest projections indicate a market value of USD 33.95 billion by 2035, fueled by an impressive CAGR of 6.43%. The rising prevalence of asthma and COPD worldwide underscores the critical need for effective medication delivery systems. As healthcare...